Microbial serotonin signalling axes in irritable bowel syndrome: integrative molecular crosstalk among enterochromaffin cells, gut microbiota, neuroimmune circuits, and precision therapeutic engineering
Archives of Microbiology · 2027
DOI: 10.1007/s00203-026-05250-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Microbiology, 2027. Verfasst von Ravinder Kumar Mehra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Geeta Institute of Pharmacy, Geeta University, Naultha, Panipat, Haryana, India. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Serotonin, Enterochromaffin Cells, Gastrointestinal Microbiome. Die Arbeit nennt 79 Literaturangaben. Gefördert von: Prince Sattam bin Abdulaziz University.
Abstract (Originalsprache)
Irritable bowel syndrome (IBS) is a common, often disabling disorder of gut-brain interaction whose molecular basis remains incompletely defined, leaving diagnosis largely symptom-based and treatment largely non-mechanistic. We argue that the serotonin (5-hydroxytryptamine; hereafter 5-HT, the primary term used throughout, with "serotonin" retained in less technical contexts) signalling axis-positioned at the interface of the gut microbiota, enterochromaffin (EC) cells, enteric neurons, and the mucosal immune system-is a central, unifying integrator of IBS pathophysiology, and that reframing IBS around this axis offers a route toward mechanism-based subtyping and therapy. We first synthesise how microbiota-driven tryptophan metabolism, short-chain fatty acid and secondary bile acid signalling, and epigenetic regulation of tryptophan hydroxylase 1 (TPH1) shape EC-cell serotonin output, before examining the neuroimmune consequences of dysregulated serotonin secretion-mast cell activation, macrophage polarisation, neurogenic inflammation-and the microbiota-serotonin-gut-brain connectome linking vagal afferent signalling, blood-brain barrier permeability, and central neurotransmitter networks. We then discuss molecular stratification of IBS subtypes through serotonergic endotyping-incorporating SLC6A4 and TPH1 polymorphisms, single-cell transcriptomics, and spatial metabolomics-and critically evaluate next-generation therapeutic strategies, including engineered probiotic chassis, CRISPR-mediated microbial editing, and AI-guided nanomedicine, distinguishing proof-of-concept findings from clinically validated approaches. We conclude that reconceptualising IBS as a disorder of disrupted microbial serotonergic ecosystems, rather than a purely symptom-defined syndrome, offers a coherent and testable framework for biomarker discovery and precision, mechanism-directed therapy, while highlighting the causal-directionality and clinical-translation gaps that must be closed before this framework can be applied at the bedside.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Geeta Institute of Pharmacy, Geeta University, Naultha, Panipat, Haryana, India.
- Department of Pharmacology, School of Pharmacy, Krishna Institute of Engineering and Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India.
- Department of Pharmacology, Saras College of Pharmacy, Sarora, Baghpat, Uttar Pradesh, India.
- Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, 11942, Saudi Arabia.
- Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, 11942, Saudi Arabia. m.anwer@psau.edu.sa.
ORCID-Profile: Md Khalid Anwer
Förderung
- Prince Sattam bin Abdulaziz University
Zitieren
APA
Mehra, R. K., Singh, B. P., Siddiqui, S., Aldawsari, M. F., Kamal, M. A., & Anwer, M. K. (2027). Microbial serotonin signalling axes in irritable bowel syndrome: integrative molecular crosstalk among enterochromaffin cells, gut microbiota, neuroimmune circuits, and precision therapeutic engineering. Archives of Microbiology. https://doi.org/10.1007/s00203-026-05250-5
Vancouver
Mehra RK, Singh BP, Siddiqui S, Aldawsari MF, Kamal MA, Anwer MK. Microbial serotonin signalling axes in irritable bowel syndrome: integrative molecular crosstalk among enterochromaffin cells, gut microbiota, neuroimmune circuits, and precision therapeutic engineering. Archives of Microbiology. 2027. doi:10.1007/s00203-026-05250-5
BibTeX
@article{Mehra2027,
author = {Mehra, Ravinder Kumar and Singh, Bhanu Pratap and Siddiqui, Shakir and Aldawsari, Mohammed F and Kamal, Mohammad Azhar and Anwer, Md Khalid},
title = {Microbial serotonin signalling axes in irritable bowel syndrome: integrative molecular crosstalk among enterochromaffin cells, gut microbiota, neuroimmune circuits, and precision therapeutic engineering},
journal = {Archives of Microbiology},
year = {2027},
doi = {10.1007/s00203-026-05250-5}
}
EUVIMED